Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment. Issue 7 (15th November 2017) - Ma, Haili; Chen, Siye; He, Yan; Huang, Jingwei; Xu, Yanhong; Wang, Chao; Lei, Cheng; Lu, Ting; Xiao, Shengdong; Mao, Jinming; Xu, Yiyun; Guo, Hao; et al.